Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
never received 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (she received the first dose of Shingrix in Feb 2023). The patient did not receive the 2nd dose of Shingrix, the patient experienced incomplete course of vaccination (Verbatim: never received 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 22-JUL-2025 Consumer stated that she received the first dose of Shingrix in Feb 2023, but she never received the second dose. Patient DOB and initials were not available. Till the time of reporting patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.